Analyst Ratings For GSK – GlaxoSmithKline (NYSE:GSK)
Today, GSK – GlaxoSmithKline (NYSE:GSK) stock received an upgrade by BNP Paribas from Neutral to Outperform.
Some recent analyst ratings include
- 4/4/2018-BNP Paribas Upgrade from a “Neutral ” rating to a ” Outperform” rating.
- 3/28/2018-Deutsche Bank Reiterated Rating of Neutral.
- 3/22/2018-Morgan Stanley Upgrade from a “Underweight ” rating to a ” Equal Weight” rating.
- 2/15/2018-Cowen Reiterated Rating of Hold.
- 2/9/2018-Kepler Capital Markets Upgrade from a “Reduce ” rating to a ” Hold” rating.
- 2/5/2018-JPMorgan Chase Reiterated Rating of Neutral.
- 1/16/2018-Barclays Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.
Dividend information for GSK – GlaxoSmithKline (NYSE:GSK)
GSK – GlaxoSmithKline (NYSE:GSK) pays an annual dividend of $2.53 with a yield of 6.44% and an average dividend growth of -8.90% based on a 3 Year Average..
Dividend History for GSK – GlaxoSmithKline (NYSE:GSK)
- On 2/7/2018 GSK – GlaxoSmithKline announced a Quarterly dividend of $0.63 6.48% with an ex dividend date of 2/22/2018 which will be payable on 4/12/2018.
- On 10/26/2017 GSK – GlaxoSmithKline announced a quarterly dividend of $0.50 5.51% with an ex dividend date of 11/9/2017 which will be payable on 1/11/2018.
- On 7/26/2017 GSK – GlaxoSmithKline announced a Quarterly dividend of $0.49 4.88% with an ex dividend date of 8/9/2017 which will be payable on 10/12/2017.
- On 4/26/2017 GSK – GlaxoSmithKline announced a quarterly dividend of $0.48 4.79% with an ex dividend date of 5/10/2017 which will be payable on 7/13/2017.
- On 2/8/2017 GSK – GlaxoSmithKline announced a quarterly dividend of $0.57 5.76% with an ex dividend date of 2/22/2017 which will be payable on 4/13/2017.
- On 10/26/2016 GSK – GlaxoSmithKline announced a dividend of $0.46 with an ex dividend date of 11/2/2016 which will be payable on 1/12/2017.
- On 7/27/2016 GSK – GlaxoSmithKline announced a dividend of $0.49 with an ex dividend date of 8/10/2016 which will be payable on 10/13/2016.
Recent Insider Trading Activity For GSK – GlaxoSmithKline (NYSE:GSK)
GSK – GlaxoSmithKline (NYSE:GSK) has insider ownership of 10.00% and institutional ownership of 10.96%.
- On 11/6/2017 Plc Glaxosmithkline, Major Shareholder, bought 428,571 with an average share price of $14.00 per share and the total transaction amounting to $5,999,994.00.
- On 10/24/2016 Plc Glaxosmithkline, Major Shareholder, bought 66,500 with an average share price of $14.00 per share and the total transaction amounting to $931,000.00.
Recent Trading Activity for GSK – GlaxoSmithKline (NYSE:GSK)
Shares of GSK – GlaxoSmithKline closed the previous trading session at with 39.15999984741211 shares trading hands.